Press Releases

Jan 14, 2020

ProBioGen and Lava Therapeutics Sign Cell Line Development and GMP Manufacturing Agreement for Novel Bispecific Molecule

read more ProBioGen and Lava Therapeutics Sign Cell Line Development and GMP Manufacturing Agreement for Novel Bispecific Molecule

download PDF

Jan 08, 2020

ProBioGen inks next Commercial GlymaxX® License with Roche

read more ProBioGen inks next Commercial GlymaxX® License with Roche

download PDF

Nov 07, 2019

DirectedLuck, a Transposase for Efficient Gene Delivery and High-Titer Cell Line Development

read more DirectedLuck, a Transposase for Efficient Gene Delivery and High-Titer Cell Line Development

download PDF

Oct 01, 2019

ProBioGen and Ceva Santé Animale sign an exclusive license agreement to produce vectorised poultry vaccines using AGE1.CR® production technology

read more ProBioGen and Ceva Santé Animale sign an exclusive license agreement to produce vectorised poultry vaccines using AGE1.CR® production technology

download PDF

Sep 10, 2019

ProBioGen licenses GlymaxX® Technology to Bayer

read more ProBioGen licenses GlymaxX® Technology to Bayer

download PDF

May 23, 2019

ProBioGen and Abcuro signed GlymaxX®-Improved Cell Line Development and GMP Production Agreement

read more ProBioGen and Abcuro signed GlymaxX®-Improved Cell Line Development and GMP Production Agreement

download PDF

May 15, 2019

ProBioGen and Vaccitech Sign License Agreement for ProBioGen’s Technology Platform

read more ProBioGen and Vaccitech Sign License Agreement for ProBioGen’s Technology Platform

download PDF

May 07, 2019

ESACT Inaugural Innovation Award to honor ProBioGen’s CSO Dr. Volker Sandig

read more ESACT Inaugural Innovation Award to honor ProBioGen’s CSO Dr. Volker Sandig

download PDF

Jan 22, 2019

CRISPR Therapeutics and ProBioGen Sign Collaboration and License Agreement to Develop Novel In Vivo Delivery Technologies

read more CRISPR Therapeutics and ProBioGen Sign Collaboration and License Agreement to Develop Novel In Vivo Delivery Technologies

download PDF

Jan 03, 2019

ProBioGen’s GlymaxX® ADCC Enhancement Technology used by Betta Pharmaceuticals

read more ProBioGen’s GlymaxX® ADCC Enhancement Technology used by Betta Pharmaceuticals

download PDF

Page 5 of 11

ProBioGen News

Join our news and always be up-to-date.

Sign up